Ann: Successful Completion of In Vitro Studies, page-9

TT,
You appear to be a bit cynical on Brian and the NTI potential.

There are over 50 published studies all using CBD alone to treat various Neuro- inflammatory conditions. Some have been positive and some negative. There are currently over 10 registered clinical trials in the USA assessing CBD in MS and chronic fatigue.

Whether we like it or not CBD is the standard which we must compare our strains to.

We are the first group to conduct these studies and have clearly demonstrated that our full plants are more powerful than CBD alone.

And in the words of Prof Michael Fahey , "Preclinical studies suggest that these strains exhibit Potent and Unique properties when compared to cud alone and Warrant the further assessment of these strains in phase 1 clinical trials"-- Bring on the human study !!.

I believe the market has got this wrong and have bought more today.

GLTAH

Cheers